Illumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics

Reuters

Oct 15, 2025

<a href="https://laohu8.com/S/ILMN">Illumina</a>'s New <a href="https://laohu8.com/S/CEG">Constellation</a> Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics

Illumina Inc. has announced that Joe Devaney will present the results of GeneDx's expanded, 160-sample study involving Illumina's Constellation technology at the ASHG Annual Meeting in Boston. The presentation, titled "Mapping the Future of Whole Genome Sequencing with Illumina Constellation Technology," is scheduled for October 15 and will take place in Room 153ABC from 12:00 PM to 1:00 PM ET. According to Illumina, the Constellation mapped read technology demonstrated improved accuracy, speed, and ease of use in identifying difficult-to-map genomic variants, outperforming orthogonal methods in this pilot study. Results have not yet been presented and will be disclosed at the upcoming conference.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA98369) on October 15, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2575780934"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2575780934\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2575780934?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-15 21:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2575780934","market":"nz","top_or_hot":-1,"title":"Illumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ILMN\">Illumina</a>'s New <a href=\"https://laohu8.com/S/CEG\">Constellation</a> Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ILMNV\">Illumina Inc</a>. has announced that Joe Devaney will present the results of GeneDx's expanded, 160-sample study involving Illumina's Constellation technology at the ASHG Annual Meeting in Boston. The presentation, titled \"Mapping the Future of Whole Genome Sequencing with Illumina Constellation Technology,\" is scheduled for October 15 and will take place in Room 153ABC from 12:00 PM to 1:00 PM ET. According to Illumina, the Constellation mapped read technology demonstrated improved accuracy, speed, and ease of use in identifying difficult-to-map genomic variants, outperforming orthogonal methods in this pilot study. Results have not yet been presented and will be disclosed at the upcoming conference.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA98369) on October 15, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Illumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIllumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-15 21:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/ILMN\">Illumina</a>'s New <a href=\"https://laohu8.com/S/CEG\">Constellation</a> Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ILMNV\">Illumina Inc</a>. has announced that Joe Devaney will present the results of GeneDx's expanded, 160-sample study involving Illumina's Constellation technology at the ASHG Annual Meeting in Boston. The presentation, titled \"Mapping the Future of Whole Genome Sequencing with Illumina Constellation Technology,\" is scheduled for October 15 and will take place in Room 153ABC from 12:00 PM to 1:00 PM ET. According to Illumina, the Constellation mapped read technology demonstrated improved accuracy, speed, and ease of use in identifying difficult-to-map genomic variants, outperforming orthogonal methods in this pilot study. Results have not yet been presented and will be disclosed at the upcoming conference.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA98369) on October 15, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7084","symbol_name":"电子设备和仪器","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251015:nNDL9QmmlH:1","article_id":"2575780934","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2575780934","pubTimestamp":1760534206,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Illumina Inc. has announced that Joe Devaney will present the results of GeneDx's expanded, 160-sample study involving Illumina's Constellation technology at the ASHG Annual Meeting in Boston. The presentation, titled \"Mapping the Future of Whole Genome Sequencing with Illumina Constellation Technology,\" is scheduled for October 15 and will take place in Room 153ABC from 12:00 PM to 1:00 PM ET. According to Illumina, the Constellation mapped read technology demonstrated improved accuracy, speed, and ease of use in identifying difficult-to-map genomic variants, outperforming orthogonal methods in this pilot study. Results have not yet been presented and will be disclosed at the upcoming conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7084":"电子设备和仪器","ILMN":"Illumina","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4548":"巴美列捷福持仓","BK4534":"瑞士信贷持仓","BK4535":"淡马锡持仓","BK4121":"生命科学工具和服务","CT1.AU":"Constellation Technologies Ltd"},"translate_title":"Illumina新Constellation技术在罕见病基因组学GeneDx临床研究中优于传统方法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CT1.AU":0.9,"ILMN":0.9},"content_text":"Illumina's New Constellation Technology Outperforms Traditional Methods in GeneDx Clinical Study for Rare Disease Genomics\n    \n\nIllumina Inc. has announced that Joe Devaney will present the results of GeneDx's expanded, 160-sample study involving Illumina's Constellation technology at the ASHG Annual Meeting in Boston. The presentation, titled \"Mapping the Future of Whole Genome Sequencing with Illumina Constellation Technology,\" is scheduled for October 15 and will take place in Room 153ABC from 12:00 PM to 1:00 PM ET. According to Illumina, the Constellation mapped read technology demonstrated improved accuracy, speed, and ease of use in identifying difficult-to-map genomic variants, outperforming orthogonal methods in this pilot study. Results have not yet been presented and will be disclosed at the upcoming conference.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA98369) on October 15, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}